Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Kimura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Kimura, J.

(Stroke. 1998;29:570-576.)
© 1998 American Heart Association, Inc.


Original Contributions

Adverse Effect of Nighttime Blood Pressure on the Outcome of Lacunar Infarct Patients

Yasumasa Yamamoto, MD; Ichiro Akiguchi, MD; Kaiyo Oiwa, MD; Masamichi Hayashi, MD; Jun Kimura, MD

From the Department of Neurology, Kyoto Second Red Cross Hospital (Y.Y., K.O., M.H.), and the Department of Neurology, Kyoto University (Japan) (I.A., J.K.).

Correspondence to Yasumasa Yamamoto, MD, Department of Neurology, Kyoto Second Red Cross Hospital, 355–5 Haruobicho Kamigyoku, Kyoto 602, Japan.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose—Antihypertensive therapy has dramatically reduced the incidence of stroke recurrence; however, recent studies have suggested that the excessive lowering of blood pressure (BP) could cause ischemic cerebral lesions. We conducted a prospective study using MRI and ambulatory blood pressure monitoring to elucidate the appropriate BP control level for the prevention of silent and symptomatic cerebral infarction.

Methods—We studied 105 patients with symptomatic lacunar infarcts who underwent repeated MRI and 24-hour BP monitoring in the period between the two MRI examinations. The patients were divided into five groups according to their outcome as follows: group 1, those who showed neither symptomatic episodes nor the development of new silent lesions detected by repeated MRI; group 2, those who only showed the development of silent lacunae; group 3, those who showed development of diffuse white matter lesions only; group 4, those who showed the development of both silent lacunae and diffuse white matter lesions; and group 5, those who showed symptomatic cerebrovascular disease. Groups 2 through 5 were then compared with group 1 with respect to the ambulatory BP values.

Results—The average follow-up period was 3.2±2.6 years (mean±SD). In all patients in group 4 and group 5, nighttime systolic BPs were significantly higher than in group 1 (both P<.01), and the magnitude of the nocturnal systolic BP dip and diastolic BP dip in group 4 and group 5 were significantly smaller than in group 1 (all P<.01). In patients who took antihypertensive agents, the 24-hour systolic and diastolic BPs and nighttime systolic and diastolic BPs in group 4 were significantly higher than in group 1 (P<.01, P<.01, P<.001, P<.01, respectively). The magnitude of the nocturnal systolic and diastolic BP dip in group 5 was significantly smaller than in group 1 (both P<.01).

Conclusions—A high average ambulatory BP, especially nighttime BP, and a reduced nocturnal BP dip may have an adverse effect on the development of silent ischemic lesions and symptomatic stroke attack in patients with lacunar infarcts.


Key Words: Binswanger's disease • blood pressure, nocturnal • lacunar infarction • white matter


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The issue of the control of blood pressure levels in stroke prevention remains unresolved. Uncontrolled hypertension has been shown to produce arteriosclerosis in small vessels and atherosclerosis in medium-sized vessels in the brains of experimental animals with hypertension.1 2 Antihypertensive medications can prevent these pathological changes in medium-sized vessels.3 Antihypertensive therapy reduces cerebrovascular and cardiovascular morbidity and mortality in humans with chronic hypertension.4 5 6 7 8 9 Nevertheless, several studies have suggested that an excessive lowering of BP can cause ischemic stroke10 11 12 13 14 and a decline in cognitive function.15 These studies also suggest that decreased BP might reduce cerebral blood flow, especially in chronic stroke patients in whom an upward shift of the autoregulatory range was recognized after the acute period had passed,16 even though it is widely thought that a high sustained BP may accelerate pathological changes in the cerebral vessels of the brain.17 18 19 Irie and his colleagues14 reported that the J-curve phenomenon, in which there is a point beyond which BP reduction in hypertensive subjects is no longer beneficial and possibly even deleterious, which has been recognized in cardiac events,20 was also found in ischemic stroke recurrences.

The studies mentioned above were conducted with casual BP values. Since the introduction of ABPM devices, many reports have demonstrated that hypertensive target organ damage can be more accurately demonstrated by the 24-hour monitored BP than by the casual BP.21 22 23 Most authors have reported that nondippers, patients with an absent or decreased nocturnal dip in their BP, tended to have more severe target organ damage, including cerebrovascular disease,21 24 25 than dippers with a normal nocturnal dip in BP. Verdecchia et al26 conducted a prospective study and reported that cardiovascular morbidity was higher in nondippers than in dippers among women. Conversely, recent reports have suggested that excessive falls in the nighttime BP27 28 or a lowering of nighttime BP by antihypertensive agents29 could produce cerebral ischemic lesions. Therefore, the issue as to what degree the nighttime BP should be controlled also remains unresolved.

Since 1990, we have been pursuing a prospective study to clarify the appropriate BP for the prevention of silent and symptomatic infarctions and to test whether the J-curve phenomenon exists for the daytime BP or nighttime BP.

Because both lacunar infarcts and diffuse white mater lesions are related to small artery disease (in which hypertension may play a major role), we restricted the subjects to lacunar infarct patients. We then followed them by tracking the progression of silent lesions, which consisted of lacunar infarcts and diffuse white mater lesions, as well as the recurrence of cerebrovascular disease by using MRI and ABPM.


*    Subjects and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Subjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subjects
We studied 105 patients with symptomatic lacunar infarcts that were located in the supratentorial region; those patients were followed up with MRI and 24-hour BP monitoring. The patients were selected in the following manner. Two hundred eighty-five patients with symptomatic lacunar infarcts for the first time were treated in our clinic at Kyoto Second Red Cross Hospital between January 1991 and December 1996. Of these 285 patients, 182 who had undergone 24-hour BP monitoring for over 4 weeks after ictus were registered in this study and were informed that follow-up MRI scans would be conducted in the future. All of the patients consented to participate in this study. Excluded were 28 patients in whom the dosage and kinds of antihypertensive agents had been changed after 24-hour BP monitoring, 22 patients who had not undergone a repeat MRI during the follow-up period, 23 patients who had dropped out, and 4 patients who had died. Thus a total of 105 patients who underwent repeat MRI as well as 24-hour BP monitoring in the period between the two MRI examinations were enrolled in this study. Patients who had embologenic cardiac disease and obvious atheromatous stenotic lesions as detected by MRA were excluded. Antiplatelet drugs were administrated to all of the patients.

Twenty-Four-Hour Blood Pressure Monitoring
We monitored the 24-hour BP by using a portable automatic recorder (ABPM-630, Nippon Corin Co) after the patients had undergone their first MRI examination. The accuracy of the equipment had been established30 and the pattern of circadian BP change were thought to be reproduced well in same person.31 The 24-hour BP monitoring was carried out in an outpatient office and was managed by the authors of this study during a period in which each patient's BP appeared to be appropriately controlled as detected by the casual BP, with and without antihypertensive drugs. The goals of the casual BP control were determined as follows: SBPs were controlled below the level of 160 mm Hg in patients who were 69 years old or younger; 170 mm Hg in patients who were 70 to 79 years old; and 180 mm Hg in patients who were 80 to 89 years old; DBPs were controlled below the level of 95 mm Hg in all age groups. Blood pressure was recorded at 30-minute intervals over 24 hours from 1 PM to 1 PM next day. ABP values, including the average 24-hour BP, daytime BP, and nighttime BP, were calculated as follows. SBP and DBP were averaged over successive 30-minute periods throughout the 24-hour period. The mean daytime (6 AM to 10 PM) and nighttime (10:30 PM to 5:30 AM) BP values were also calculated. The magnitude of the nocturnal BP dip was calculated as [(mean daytime BP-mean nighttime BP)/average BP for the entire 24 hours]x100.

Magnetic Resonance Imaging
MRI scans were performed with 1.0-T superconducting magnets (Impact, Siemence) at least twice during the follow-up period. The first MRI was performed during the period from 14 days to 42 days after ictus of lacunar stroke. A diagnosis of lacunar stroke was made when both lacunar syndrome and lacunar infarcts were confirmed in the MRI scan. Basically, patients underwent MRI once a year, and several patients who seemed to be less well controlled, every 6 months. Transverse T1-weighted scans (TR: 525 ms/TE: 14 ms), T2-weighted scans (TR: 3500 ms/TE: 16 ms), and proton density images (TR: 3500 ms/TE: 98 ms) were obtained at a slice thickness of 8 mm. We evaluated the lacunar and diffuse white matter lesions on the baseline MRI. Lacunae were defined as lesions greater than 3 mm but less than 10 mm in diameter and with low intensity on T1-weighted images but high intensity on T2-weighted and proton density images. The number of lacunae was counted and graded as 0, absent; 1, one to two lacunae; 2, three to five lacunae; and 3, more than six lacunae. Diffuse white matter lesions were defined as diffuse hyperintensities on T2-weighted images and proton density images, which were located in the white matter and were specified and graded according to Fazekas's classification32 into 0, absent; 1, punctuate; 2, becoming confluent; and 3, confluent. Hyperintense periventricular caps and smooth halos were not counted as diffuse white matter lesions.33 Both baseline MRI and final MRI were evaluated by two authors (Y.Y. and I.A.) who were blinded to the BP data and the outcome data. The mean period between the first and last MRI was 3.2±2.6 years (mean±SD).

Patient Follow-up
We followed up the subjects prospectively at our outpatient clinic until March 31, 1997. Most patients (90) were seen once a month and some patients (15) every 2 or 3 months in outpatient clinic. Those who had new neurological deficits that continued for more than 24 hours were estimated as having symptomatic cerebrovascular disease. In those patients with no symptomatic cerebrovascular disease, we compared the final MRI with the first MRI to detect whether new lesions, including lacunae and diffuse white matter lesions, had developed. Patients were divided into five groups according to their prognosis as follows: group 1, those who showed neither symptomatic episodes nor the development of new silent lesions as detected by repeated MRI; group 2, those who showed the development of silent lacunae only; group 3, those who showed development of diffuse white matter hyperintensities only; group 4, those who showed the development of both silent lacunae and diffuse white matter lesions; and group 5, those who showed symptomatic cerebrovascular disease. Division of the patients into five groups was based on the speculation that asymptomatic and symptomatic infarcts or lacunar infarcts and leukoaraiosis could be influenced differently by BP. We ordered severity as follows: symptomatic infarcts, asymptomatic lacune, and diffuse white matter lesions.

Statistical Analysis
Statistical comparisons among the five groups were performed with a one-way ANOVA for parametric values and with a Kruskal-Wallis test for nonparametric categories. When there were differences among the five groups, groups 2 through 5 were each compared by Bonferroni's method with group 1, which had the best prognosis. In analyzing the distribution of sex and risk factors among the groups, a {chi}2 test was used. The values were expressed as mean±SD. A value of P<.05 was considered statistically significant, but a value of P<.0125 was considered to be statistically significant by Bonferroni's method.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Classification by Outcomes
We obtained complete tracking data from 105 of the 182 patients who entered the study from January 1991 through December 1997. The mean duration of tracking was 3.2 years (range, 6 to 74 months). The 105 patients studied for the entire period were divided into five groups: group 1, 50 patients in whom the MRI findings had not changed; group 2, 16 patients in whom a silent lacuna or lacunae had developed; group 3, 14 patients in whom white matter hyperintensities had developed; group 4, 11 patients in whom both silent lacunae and white matter hyperintensities had developed; and group 5, 15 patients in whom symptomatic cerebral infarctions had developed. (Symptomatic cerebral infarctions consisted of 13 lacunar infarcts and 2 cortical infarcts.) The patient characteristics for each group, including age, sex, complications from diabetes mellitus and hypercholesterolemia, smokers, and the degree of lacunar and white matter lesions on baseline MRI findings, are given in Table 1Down. Groups 2 through 5 were then compared with group 1 with respect to these items.


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of Patients in Five Groups Divided by Outcome

There were no significant differences among the five groups in age, sex, complications from diabetes mellitus, hypercholesterolemia, smokers, and the degree of lacune, although the percentages of diabetes mellitus and hypercholesterolemia tended to be higher in groups 4 and 5. There were significant differences among the five groups in the degree of diffuse white matter lesions (P=.0015) (ANOVA). However, when groups 2 though 5 were each compared with group 1, there were no significant differences.

Casual and ABP Values Between Groups
The mean values and standard deviations at which the casual BPs were controlled, the average 24-hour BP, daytime BP, nighttime BP, and the magnitude of the nocturnal BP dip are given in Table 2Down. The patients whose casual BPs were not controlled within the range that we had described in the "Methods" section were as follows: three patients in group 1, three in group 2, two in group 3, two in group 4, and two in group 5. Compared with group 1, groups 2 through 5 had significantly higher systolic nighttime BPs (group 4, P=.002, and group 5, P=.002), smaller magnitude of the nocturnal SBP dip (group 4, P=.001, and group 5, P=.01), higher nighttime BP (group 4, P=.003), and smaller magnitude of the nocturnal DBP dip (group 4, P=.001, and group 5, P=.005) (Table 2Down).


View this table:
[in this window]
[in a new window]
 
Table 2. Comparison of Blood Pressure Values Among the Five Groups

Sex Differences
All of the patients in each group were divided into male (72 patients) and female (33 patients) subgroups. The ABP values were then compared across severity groups including both D(+) and D(-) within each sex. In both men and women, there were no significant differences among the five groups in any of the ABP values (ANOVA).

Antihypertensive Treatment
All of the patients studied were then divided into two groups: group D(-), 35 patients who did not take antihypertensive agents, and group D(+), 70 patients who took antihypertensive agents. Their mean casual BP, average 24-hour BP, daytime BP, nocturnal BP, and the magnitude of their nocturnal BP dip in group D(-) and group D(+) are given in Table 2Up.

Patients Without Antihypertensive Treatment
Compared with group D(-)1, groups D(-)2 through D(-)5 had significantly smaller magnitude of the nocturnal DBP dip [group D(-)4 (P=.002)]. The daytime and nighttime BPs for the five groups are plotted in Fig 1Down.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 1. ABPs (upper: daytime; bottom: nighttime; left: SBP; right: DBP) in patients who did not take antihypertensive agents [D(-)].

Patients With Antihypertensive Treatment
Compared with group D(+)1, groups D(+)2 through D(+)5 had significantly higher 24-hour SBP [group D(+)4 (P=.001)], higher nighttime SBP [groups D(+)4 (P=.0003) and D(+)5 (P=.005)], lower magnitude of nocturnal SBP dip [group D(+)5 (P=.003)], higher 24-hour DBP [group D(+)4 (P=.002)], higher daytime DBP [group D(+)4 (P=.008)], higher nighttime DBP [group D(+)4 (P=.001)], and lower magnitude of the nocturnal DBP dip [group D(+)5 (P=.006)] (Table 2Up). The daytime and nighttime BPs for the five groups are plotted in Fig 2Down. There were no patients who showed an excessively low BP in the daytime or at night in groups D(+)2 through D(+)5.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 2. ABPs (upper: daytime; bottom: nighttime; left: SBP; right: DBP) in patients who took antihypertensive agents [D(+)]. Groups 2 through 5 are compared with group 1. {dagger}P<.01, {ddagger}P<.001.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
*Discussion
down arrowReferences
 
This study demonstrated that a high ambulatory BP, especially at night, and a reduced nocturnal BP dip were both associated with the development of silent ischemic lesions (both lacunar and diffuse white matter lesion) and symptomatic ischemic stroke recurrences in lacunar infarct patients. No patients showed the development of new lesions caused by an excessive lowering of their daytime or nighttime BP. Unlike other studies, our study did not find that the J-curve phenomenon14 was present or that an excessive fall in the nighttime BP27 28 29 caused cerebral ischemic lesions.

Over the past few decades, a considerable number of longitudinal studies have been performed on the relationship between BP and stroke, and most have demonstrated that a high BP is strongly related to stroke occurrence.4 5 6 7 8 9 Most of these studies, however, were based on the casual BP and symptomatic cerebrovascular disease. The introduction of the ABPM and MRI have now made it possible for us to study the relation of BP to the development of cerebrovascular lesions more precisely, including silent cerebrovascular lesions. This study is the first that was performed prospectively with ABPM and MRI. We restricted the subjects to patients with lacunar infarcts, which are believed to be directly related to hypertension, and excluded those patients with atherothrombotic occlusion and stenosis, so that we could explore the relation between BP and ischemic cerebrovascular lesions more precisely by studying a homogeneous patient group.

A high average ambulatory BP, especially at night, had a high correlation with the development of both lacunar and white matter lesions in the group that did not take antihypertensive agents [group D(-)] and in the group that took antihypertensive agents [group D(+)]. This correlation was demonstrated more clearly in group D(+) than in group D(-). These results have much in common with the previous cross-sectional studies that suggested that the nocturnal BP had a higher correlation with target organ damage than the casual or daytime BP. It has been assumed that persistent pressure overload would increase the progression of hypertensive organ damage.21 22 23 26 34 35 We conclude that the findings in this longitudinal study have directly supported these assumptions.

Both lacunar and white matter lesions have been believed to be strongly associated with hypertension.36 37 38 39 In this study, lacunae were identified only when they were located in the basal ganglia, subcortical white matter, and pons. This appears to be compatible with Fisher's definition,36 in which lacunae are infarcts caused by the occlusion of branches of perforating arteries. Lesions that measured less than 3 mm were not counted as lacunae, so as to exclude état criblé. We identified diffuse white matter lesions when they were located in the deep subcortical white matter, which might correspond to characteristic pathological findings, including a focal area with the prominent loss of myelin and axons, small ischemic, microcystic infarcts, and associated gliosis. These kinds of lesions are considered to reflect ischemic tissue damages.33 We excluded periventricular caps and smooth halos, which consist of decreased myelin content, the loss of the ependymal cell layer, and reactive gliosis,40 from diffuse white matter lesions.

In group D(+)2 and D(+)3, lacunar and diffuse white matter lesions developed, respectively. The nighttime BP tended to be higher in these two groups, although not significantly when compared with group D(+)1. It seems possible that a high nighttime BP might produce either lacunar or diffuse white matter lesions. Moreover, it is clear that a higher nighttime BP causes both lacunar and diffuse white matter lesions to occur at the same time. In patients in whom both lacunar and diffuse white matter lesions have developed, a progression to Binswanger's disease41 42 is likely. In actual fact, the severity of diffuse white matter lesions on the first MRI tended to be greater in group 4 than in the other groups. Some of the patients in these groups could have been classified as having Binswanger's disease from the beginning, and the other patients in these groups are likely to develop Binswanger's disease. Thus a sustained high BP overnight may accelerate the development of Binswanger's disease.

The reduced nocturnal BP dip also tended to be smaller in groups 4 and 5 (Table 2Up). It is likely that a reduced nocturnal BP dip may have a high correlation with the high nighttime BP. Verdecchia et al26 reported that ambulatory hypertension and an absent nocturnal BP dip were independent predictors of cardiovascular morbidity. Verdecchia and colleagues' report may be the first longitudinal study to have demonstrated that cardiovascular morbidity was higher in nondippers than in dippers. However, Verdecchia and colleagues' study was performed on the basis of baseline, off-therapy, ambulatory BP. It appears that nondippers have a worse prognosis, as detected by their ABPs during therapeutic intervention, which we have demonstrated in this study, as well as by their baseline, off-therapy, ambulatory BP.

Over the last several years, two questions have been the subject of controversy: whether a diminished nocturnal BP dip is the cause or the consequence of hypertensive organ damage and whether this condition has a beneficial or a harmful effect on organ damage. Traditionally, there have been two different views: one was that sustained high BP overnight might have adverse effects on end-organ damage21 22 23 26 34 35 and the other was that a diminished nocturnal BP dip might protect against end-organ damage caused by a decrease in the blood flow during sleep.43 This study demonstrated that nondippers tended to have a worse prognosis than dippers in longitudinal studies. As Table 2Up indicates, a reduced nocturnal BP and/or high ABPs appeared to be responsible for the new lesions and events observed in groups 4 and 5.

There are reports attributing nondipper mechanisms to autonomic disturbance. We showed that autonomic disturbances play a role as one of the mechanisms associated with a diminished nocturnal BP decline.25 Kohara et al44 showed that the nondipper phenomenon was due to the failure of withdrawal of sympathetic tone at night, and Ebata et al45 pointed out that increased {alpha}1-adrenergic receptor stimulation might be one of the primary causes of a high nighttime BP in nondippers. Thus it may be safely assumed that central autonomic disturbances, which are present in nondippers, might impair their ability to control their BP and cerebral blood flow and thus might accelerate end-organ damage. Therefore a reduced nocturnal BP dip, with or without high average ambulatory BP, may have adverse effects on end organ damage.

In this study, it appears that there were no patients in whom an excessively low BP, in either their daytime or nighttime BP, might have accelerated ischemic lesions (Fig 2Up). Our results differ from those in which the J-curve phenomenon was recognized14 and in which an excessive nocturnal BP dip was thought to cause new lesions.27 28 One of the reasons for this difference may be the fact that the patient BP was controlled at a relatively high level in this study. The high BP levels in our study were due to control, based on the theory of cerebral autoregulation, and we also had some patients in whom BP was unresponsive to medication. Another reason our results differ from those in which the J-curve phenomenon was recognized is that we restricted our subjects to patients with lacunar infarcts and excluded those with atherothrombotic lesions. Kario et al27 and Watanabe et al28 hypothesized that in their cross-sectional studies, an excessive nocturnal BP dip might have caused silent cerebrovascular lesions. Our longitudinal study did not support this view. It is likely that a high daytime BP in those patients with an excessive nocturnal BP dip, rather than the nocturnal BP dip itself, accelerates silent cerebrovascular lesions.46

It should be noted that if dippers and nondippers were equated according to their daytime BP, the average 24-hour BP or nighttime BP would be higher in the nondippers. Because BP is usually monitored on the basis of the casual BP, which is measured during the daytime, one ought to consider this fact when determining suitable BP levels throughout a 24-hour period.

A high average ABP and a reduced nocturnal BP dip may have adverse effects on the prognosis of patients with lacunar infarcts. Although multiple factors contribute to the development of new lesions, we can expect to attenuate the development of silent cerebrovascular lesions and the recurrence of stroke by controlling BP more carefully. The mechanisms by which new lesions develop might go beyond these results. Further investigation is necessary to clarify these issues.


*    Selected Abbreviations and Acronyms
 
ABP = ambulatory blood pressure
ABPM = ABP monitoring
BP = blood pressure
DBP = diastolic BP
SBP = systolic BP

Received September 3, 1997; revision received December 18, 1997; accepted December 18, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Limas C, Westrum B, Limas C. The evolution of vascular changes in the spontaneously hypertensive rat. Am J Pathol. 1976;121:119–129.
  2. Tagami M, Nara Y, Kubota A, Sunaga T, Maezawa H, Fujino H, Yamori Y. Ultrastructural characteristics of occluded perforating arteries in stroke-prone spontaneously hypertensive rats. Stroke. 1987;18:733–740.[Abstract/Free Full Text]
  3. Goldby FS, Bellin LJ. The evolution and healing in arteriolar damage in renal clip hypertension in rat: an electron microscope study. J Pathol. 1974;114:139–148.[Medline] [Order article via Infotrieve]
  4. Omae T, Ueda K. Hypertension and cerebrovascular disease-the Japanese experience. J Hypertens. 1988;6:343–349.[Medline] [Order article via Infotrieve]
  5. Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G. Primary prevention with metoprolol in patients with hypertension. JAMA. 1988;249:1976–1982.
  6. 1988 Joint National Committee. The report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1988;148:1023–1038.[Abstract]
  7. Garraway WM, Whisnant JP. The changing pattern of hypertension and the declining incidence of stroke. JAMA. 1987;258:214–217.[Abstract]
  8. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the multiple risk factor intervention trial. Circulation. 1988;77:504–514.[Abstract/Free Full Text]
  9. Kinnander G, Viitanen M, Asplund K. Beta-adrenergic blockade after stroke: a preliminary cohort study. Stroke. 1987;18:240–243.[Abstract/Free Full Text]
  10. Jackson G, Pierscianowski TA, Manhohn W, Condon J. Inappropriate antihypertensive therapy in the elderly. Lancet. 1976;2:1317–1318.[Medline] [Order article via Infotrieve]
  11. Kelley R, Kovacs AG. Mechanism of in-hospital ischemia. Stroke. 1986;17:430–433.[Abstract/Free Full Text]
  12. Dobkin BH. Orthostatic hypotension as a risk factor for symptomatic occlusive cerebrovascular disease. Neurology. 1989;39:30–34.[Abstract/Free Full Text]
  13. Jansen PA, Schulte BPM, Meyboom RHB, Gribnau FWJ. Antihypertensive treatment as a possible cause of stroke in elderly. Age Aging. 1986;15:1139–1141.
  14. Irie K, Yamaguchi T, Minematsu K, Omae T. The J-curve phenomenon in stroke recurrence. Stroke. 1993;24:1844–1849.[Abstract/Free Full Text]
  15. Meyer JS, Judd BW, Tawaklna T, Rogers RL, Mortel KF. Improved cognition after control of risk factors for multi-infarct dementia. JAMA. 1986;256:2203–2209.[Abstract]
  16. Strandgaard S, Olesen J, Skinhj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. BMJ. 1973;1:507–510.
  17. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488–500.[Medline] [Order article via Infotrieve]
  18. Harper SL. Effect of antihypertensive treatment on the cerebral microvasculature of spontaneously hypertensive rat. Stroke. 1987;18:450–456.[Abstract/Free Full Text]
  19. Ibayashi S, Ogata J, Sadoshima S, Fujii K, Yao H, Fujishima M. The effect of long-term antihypertensive treatment on medial hypertrophy of cerebral arteries in spontaneously hypertensive rats. Stroke. 1986;17:515–519.[Abstract/Free Full Text]
  20. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;1:581–583.[Medline] [Order article via Infotrieve]
  21. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly: correlation with ambulatory pressure. Hypertension. 1990;16:692–699.[Abstract/Free Full Text]
  22. Verdecchia P, Schillaci G, Guerrieti M, Gatteschi C, Benemino G, Boldrini F, Procellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528–536.[Abstract/Free Full Text]
  23. Kuwajima I, Suzuki Y, Shimosawa T, Kanemaru A, Hoshino S, Kuramoto K. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J. 1992;67:1307–1311.
  24. Tohgi H, Chiba K, Kimura M. Twenty-four-hour variation of blood pressure in vascular dementia of Binswanger type. Stroke. 1991;7:477–483.
  25. Yamamoto Y, Akiguchi I, Oiwa K, Satoi H, Kimura J. Diminished nocturnal blood pressure decline and lesion site in cerebrovascular disease. Stroke. 1995;26:829–833.[Abstract/Free Full Text]
  26. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793–801.[Abstract/Free Full Text]
  27. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130–135.[Abstract/Free Full Text]
  28. Watanabe N, Imai Y, Nagai K, Tsuji I, Satoh H, Sakuma M, Sakuma H, Kato J, Onodera-Kikuchi H, Yamada M, Abe F, Hisamichi S, Abe K. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke. 1996;27:1319–1327.[Abstract/Free Full Text]
  29. Nakamura K, Oita J, Yamaguchi T. Nocturnal blood pressure dip in stroke survivors: a pilot study. Stroke.. 1995;26:1373–1378.[Abstract/Free Full Text]
  30. White WB, Lund-Johansen P, McCabe EJ. Clinical evaluation of the Colin ABPM 630 at rest and during exercise: an ambulatory blood pressure monitor with gas-powered cuff inflation. J Hypertens. 1989;7:477–483.[Medline] [Order article via Infotrieve]
  31. Weber MA, Drayer JI, Nakamura DK, Wyle FA. The circadian blood pressure pattern in ambulatory normal subjects. Am J Cardiol. 1984;1:115–119.
  32. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol. 1987;8:421–426.
  33. Fazekas F, Kleinert R, Offenbacher H, Shumidt R, Kleinert G, Payer F, Randner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology.. 1993;43:1683–1689.[Abstract/Free Full Text]
  34. Rizzoni D, Muiesan L, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens. 1992;5:180–186.[Medline] [Order article via Infotrieve]
  35. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, Pessina AC. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med. 1992;152:1855–1860.[Abstract]
  36. Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology. 1965;15:774–784.
  37. Lechner H, Schmidt R, Bertha G, Justich E, Offenbacher H, Schneider G. Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals. Stroke.. 1988;19:263–265.[Abstract/Free Full Text]
  38. Zimmerman RD, Fleming CA, Lee BCP, Saint-Louis LA, Deck MDF. Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJNR Am J Neuroradiol. 1986;7:13–20.
  39. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly: correlation with age and cerebrovascular risk factors. Stroke. 1986;17:1084–1089.[Abstract/Free Full Text]
  40. Sez G, Armond SJ, Brant-Zawadzki M, Davis RL, Norman D, Newton TH. Foci of MRI signal (pseudolesions) anterior to the frontal horn: histologic correlations of a normal finding. AJNR Am J Neuroradiol. 1986;7:381–387.
  41. Fisher CM. Binswanger's encephalopathy: a review. J Neurol. 1989;236:65–79.[Medline] [Order article via Infotrieve]
  42. Caplan LR. Binswanger's disease revisited. Neurology.. 1995;45:626–633.[Free Full Text]
  43. Imai Y, Abe K, Munakata M, Sakuma H, Hashimoto J, Imai K, Sekino H, Yoshinaga K. Circadian blood pressure variations under different pathophysiological conditions. J Hypertens. 1990;8:S125–S132.
  44. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects: evaluation by power spectral analysis of heart rate variability. Hypertension. 1995;26:808–814.[Abstract/Free Full Text]
  45. Ebata H, Hojo Y, Ikeda U, Ishida H, Natsume T, Shimada K. Differential effects of an alpha 1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens Res. 1995;18:125–130.[Medline] [Order article via Infotrieve]
  46. Pickering TG, James GD. Determinants and consequences of the diurnal rhythm of blood pressure. Am J Hypertens. 1993;6:166–169.



This article has been cited by other articles:


Home page
Age AgeingHome page
M. L. Burr, E. Dolan, E. W. O'Brien, E. T. O'Brien, and P. McCormack
The value of ambulatory blood pressure in older adults: the Dublin outcome study
Age Ageing, March 1, 2008; 37(2): 201 - 206.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. B. White
The Riskiest Time for the Brain: Could the Nighttime Be the Right Time for Intervention?
Hypertension, June 1, 2007; 49(6): 1215 - 1216.
[Full Text] [PDF]


Home page
HypertensionHome page
G. Mancia, M. Bombelli, R. Facchetti, F. Madotto, G. Corrao, F. Q. Trevano, G. Grassi, and R. Sega
Long-Term Prognostic Value of Blood Pressure Variability in the General Population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study
Hypertension, June 1, 2007; 49(6): 1265 - 1270.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Dolan, A. Stanton, L. Thijs, K. Hinedi, N. Atkins, S. McClory, E. D. Hond, P. McCormack, J. A. Staessen, and E. O'Brien
Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study
Hypertension, July 1, 2005; 46(1): 156 - 161.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Sega, R. Facchetti, M. Bombelli, G. Cesana, G. Corrao, G. Grassi, and G. Mancia
Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study
Circulation, April 12, 2005; 111(14): 1777 - 1783.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Verdecchia, F. Angeli, and R. Gattobigio
Clinical Usefulness of Ambulatory Blood Pressure Monitoring
J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S30 - 33.
[Abstract] [Full Text]


Home page
StrokeHome page
S. Aslanyan, F. Fazekas, C. J. Weir, S. Horner, and K. R. Lees
Effect of Blood Pressure During the Acute Period of Ischemic Stroke on Stroke Outcome: A Tertiary Analysis of the GAIN International Trial
Stroke, October 1, 2003; 34(10): 2420 - 2425.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. L. Clement, M. L. De Buyzere, D. A. De Bacquer, P. W. de Leeuw, D. A. Duprez, R. H. Fagard, P. J. Gheeraert, L. H. Missault, J. J. Braun, R. O. Six, et al.
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
N. Engl. J. Med., June 12, 2003; 348(24): 2407 - 2415.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Covic and D. Goldsmith
Ambulatory blood pressure monitoring: an essential tool for blood pressure assessment in uraemic patients
Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1737 - 1741.
[Full Text] [PDF]


Home page
StrokeHome page
G. de Jong, F. Kessels, and J. Lodder
Two Types of Lacunar Infarcts: Further Arguments From a Study on Prognosis
Stroke, August 1, 2002; 33(8): 2072 - 2076.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Verdecchia, G. Reboldi, C. Porcellati, G. Schillaci, S. Pede, M. Bentivoglio, F. Angeli, S. Norgiolini, and G. Ambrosio
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 878 - 885.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. Yamamoto, I. Akiguchi, K. Oiwa, M. Hayashi, T. Kasai, and K. Ozasa
Twenty-four-Hour Blood Pressure and MRI as Predictive Factors for Different Outcomes in Patients With Lacunar Infarct
Stroke, January 1, 2002; 33(1): 297 - 305.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Staaf, A. Lindgren, and B. Norrving
Pure Motor Stroke From Presumed Lacunar Infarct: Long-Term Prognosis for Survival and Risk of Recurrent Stroke
Stroke, November 1, 2001; 32(11): 2592 - 2596.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Verdecchia
Prognostic Value of Ambulatory Blood Pressure : Current Evidence and Clinical Implications
Hypertension, March 1, 2000; 35(3): 844 - 851.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. L. Dawson, B. N. Manktelow, T. G. Robinson, R. B. Panerai, and J. F. Potter
Which Parameters of Beat-to-Beat Blood Pressure and Variability Best Predict Early Outcome After Acute Ischemic Stroke?
Stroke, February 1, 2000; 31(2): 463 - 468.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C. Bassetti and M. Aldrich
Night time versus daytime transient ischaemic attack and ischaemic stroke: a prospective study of 110 patients
J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 463 - 467.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Y. H. Lip, C. R. Gibbs, and D. G. Beevers
Ambulatory Blood Pressure Monitoring and Stroke : More Questions Than Answers
Stroke, August 1, 1998; 29(8): 1495 - 1497.
[Full Text] [PDF]


Home page
StrokeHome page
A. Chamorro, Y. Yamamoto, and I. Akiguchi
Ambulatory Blood Pressure in Lacunar Infarct Patients • Response
Stroke, August 1, 1998; 29(8): 1740 - 1742.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Kimura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Kimura, J.